Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Airsculpt Technologies (AIRS) Cash & Equivalents (2020 - 2025)

Airsculpt Technologies' Cash & Equivalents history spans 6 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 9.49% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, down 9.49%, while the annual FY2024 figure was $8.2 million, 19.75% down from the prior year.
  • Cash & Equivalents for Q3 2025 was $5.4 million at Airsculpt Technologies, down from $8.2 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $35.3 million in Q2 2022 and bottomed at $10.0 in Q3 2021.
  • The 5-year median for Cash & Equivalents is $9.6 million (2022), against an average of $12.4 million.
  • The largest YoY upside for Cash & Equivalents was 75999900.0% in 2022 against a maximum downside of 62.06% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $25.3 million in 2021, then crashed by 62.06% to $9.6 million in 2022, then grew by 6.72% to $10.3 million in 2023, then fell by 19.75% to $8.2 million in 2024, then crashed by 34.37% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for AIRS's Cash & Equivalents are $5.4 million (Q3 2025), $8.2 million (Q2 2025), and $5.6 million (Q1 2025).